Fulcrum Therapeutics, Inc. (FULC) stock
FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.75+0.04 (+1.08%)
Close on Nov 17, 2026Market cap $286.12MP/E –Yield –
Fulcrum Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Fulcrum Therapeutics's price to book ratio was 0.9× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 0.6× to 4.5×, with a median of 1.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.9× | −2.2 |
| 2025 | Dec 31, 2025 | 3.1× | +2.1 |
| 2024 | Dec 31, 2024 | 1.0× | −0.4 |
| 2023 | Dec 29, 2023 | 1.4× | −0.3 |
| 2022 | Dec 30, 2022 | 1.7× | −1.4 |
| 2021 | Dec 31, 2021 | 3.1× | +0.1 |
| 2020 | Dec 31, 2020 | 3.0× | −0.6 |
| 2019 | Dec 31, 2019 | 3.7× | – |
See a number that looks wrong?